GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Float Percentage Of Total Shares Outstanding

Verastem (FRA:2VSA) Float Percentage Of Total Shares Outstanding : 99.41% (As of Jun. 21, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Verastem Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Verastem's float shares is 25.18 Mil. Verastem's total shares outstanding is 25.33 Mil. Verastem's float percentage of total shares outstanding is 99.41%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Verastem's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Verastem's Institutional Ownership is 8.47%.

Verastem Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Verastem's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=25.18/25.33
=99.41%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Verastem (FRA:2VSA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ZVRA APLT STRO STOK ALLK AKBA GLUE LYRA ATNM IKNA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
VSTM:USA 0LOV:UK
Address
117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Website
https://www.verastem.com
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem (FRA:2VSA) Headlines

No Headlines